These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 6459282)

  • 1. Vascular prostacyclin, platelet sensitivity to prostaglandins and platelet-specific proteins in diabetes mellitus. Analysis of type of diabetes, state of metabolic control and diabetic microangiopathy.
    Schernthaner G; Sinzinger H; Silberbauer K; Freyler H; Mühlhauser I; Kaliman J
    Horm Metab Res Suppl; 1981; 11():33-43. PubMed ID: 6459282
    [No Abstract]   [Full Text] [Related]  

  • 2. Platelet sensitivity to prostacyclin in diabetes mellitus.
    Pillay PK; Pillay U; Balasubramaniam P; Lee KO
    Ann Acad Med Singap; 1985 Apr; 14(2):229-31. PubMed ID: 3898978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased platelet malondialdehyde, but normal platelet sensitivity to adenosine-5-diphosphate and prostacyclin in well-controlled type 1 diabetics without vascular complications.
    Gisinger C; Schernthaner G
    Diabetes Res; 1986 Oct; 3(8):401-5. PubMed ID: 3545622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet sensitivity in vitro to adenosine-5'-diphosphate and prostacyclin and diabetic retinopathy.
    Davis TM; Bown E; Turner RC
    Diabetologia; 1985 May; 28(5):274-6. PubMed ID: 3894139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelets from diabetic subjects show diminished sensitivity to prostacyclin.
    Betteridge DJ; El Tahir KE; Reckless JP; Williams KI
    Eur J Clin Invest; 1982 Oct; 12(5):395-8. PubMed ID: 6816610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Platelet sensitivity to prostacyclin (PGI2) in patients with juvenile-onset diabetes mellitus (author's transl)].
    Klein K; Sinzinger H; Schernthaner G; Silberbauer K; Prager R
    Wien Klin Wochenschr; 1981 Jul; 93(14):460-2. PubMed ID: 7023074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet sensitivity to adenosine diphosphate and to prostacyclin in diabetic patients.
    Onodera H; Hirata T; Sugawara H; Sugai K; Yoda B; Toyota T; Goto Y
    Tohoku J Exp Med; 1982 Aug; 137(4):423-8. PubMed ID: 6750843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelets and diabetic vascular disease.
    Paton RC; Passa P
    Diabete Metab; 1983 Dec; 9(4):306-12. PubMed ID: 6230270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet aggregation and plasma levels of beta-thromboglobulin in diabetes mellitus.
    Yamada K; Mori K; Goto Y
    Tohoku J Exp Med; 1981 Dec; 135(4):423-9. PubMed ID: 6175049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paradoxical platelet behaviour in diabetic ketoacidosis.
    Campbell RR; Foster KJ; Stirling C; Mundy D; Reckless JP
    Diabet Med; 1986 Mar; 3(2):161-4. PubMed ID: 2951159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of prostaglandin and prostacyclin antagonism at platelet receptors by aggregometry.
    Eggerman TL; Harker LA; Andersen NH; Wilson CH
    Adv Prostaglandin Thromboxane Res; 1980; 6():389-93. PubMed ID: 6247888
    [No Abstract]   [Full Text] [Related]  

  • 12. Moderate exercise increases platelet function in type I diabetic patients without severe angiopathy and in good control.
    Trovati M; Anfossi G; De Facis R; Mularoni E; Massucco P; Cavalot F; Burzacca S; Mattiello L; Lucchina PG
    Diabetes Care; 1992 Nov; 15(11):1742-6. PubMed ID: 1468311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Vascular-platelet link in the hemostatic system of diabetics].
    Baluda VP; Deianov I; Balabolkin MI; Lukoianova TI; Baluda MV
    Probl Endokrinol (Mosk); 1986; 32(2):32-5. PubMed ID: 2940588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma beta-thromboglobulin, platelet factor 4, fibrinopeptide A, and other hemostatic functions during improved, short-term glycemic control in diabetes mellitus.
    Rosove MH; Frank HJ; Harwig SS
    Diabetes Care; 1984; 7(2):174-9. PubMed ID: 6203689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of platelet reactivity in diabetes mellitus.
    Kutti J; Wadenvik H; Henestam B; Stenström G
    Acta Med Scand; 1986; 219(2):195-9. PubMed ID: 2938425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Correlation between beta-thromboglobulin and metabolic compensation in diabetes type I].
    Gragnoli G; Signorini AM; Tanganelli I
    Ric Clin Lab; 1983; 13 Suppl 3():383-7. PubMed ID: 6200916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Some characteristics of spontaneous platelet aggregation in young insulin-dependent diabetic subjects.
    Paulsen EP; McClung NM; Sabio H
    Horm Metab Res Suppl; 1981; 11():15-21. PubMed ID: 6459281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of prostacyclin on platelet-activating factor induced rabbit and platelet aggregation.
    Bussolino F; Camussi G
    Prostaglandins; 1980 Nov; 20(5):781-91. PubMed ID: 6258196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet function in male diabetics with and without macrovascular complications.
    Tóth L; Szénási P; Jámbor G; Kammerer L; Romics L
    Diabetes Res Clin Pract; 1992 Feb; 15(2):143-8. PubMed ID: 1563330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aggregation and thromboxane formation by platelets and vascular prostacyclin production from BB rats. An animal model for type I diabetes.
    Landgraf-Leurs MM; Landgraf R; Loy A; Weber PC; Herberg LL
    Prostaglandins; 1982 Jul; 24(1):35-46. PubMed ID: 6812171
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.